Riskpilot← Back to searchSign inGet full accessPlus Sundhed A/S
A/SActiveCVR 31159245Stationsparken 37Residential care activities for persons living with or having a diagnosis of a mental illness or substance abuse · NACE 8720Est. 2007174 employeeswww.plussundhed.dk
Revenue 2025
DKK 34,7M
0% vs 2024
EBITDA margin
40.3%
-8% vs 2024
Equity ratio
41.6%
Financial strength
Net profit 2025
DKK 10,5M
-4% vs 2024
| Revenue | DKK 34,7M | +0% |
| EBITDA | DKK 14M | -8% |
| Net profit | DKK 10,5M | -4% |
| Total assets | DKK 34,9M | -3% |
| Equity | DKK 14,5M | -3% |
| Employees | 174 | — |
Legal name
Plus Sundhed A/S
CVR number
31159245
Legal form
Aktieselskab
NACE code
8720 · Residential care activities for persons living with or having a diagnosis of a mental illness or substance abuse
Founded
18. december 2007
Share capital
DKK 1.000.000
Employees
174 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive virksomhed med levering af ydelser på sundheds- og plejeområdet, samt at tilbyde såvel midlertidig som længerevarende ophold i boformer til personer, som på grund af betydelig nedsat fysisk eller psykisk funktionsevne eller særlige sociale problemer har behov for det, samt at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.
Address
Stationsparken 37
Phone
+4531198000
Email
info@plussundhed.dk
Website
www.plussundhed.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.580 | 9.285 | 13.558 | 13.055 | 9.851 | 18.312 | 17.873 | 18.648 | 18.901 | 23.053 | 27.158 | 31.129 | 34.636 | 34.674 |
| Staff expenses | -8.931 | -5.669 | -7.049 | -11.643 | -8.063 | -10.189 | -12.248 | -11.699 | -13.029 | -13.568 | -14.536 | -17.476 | -19.517 | -20.696 |
| EBITDA | 5.648 | 3.616 | 6.509 | 1.412 | 1.788 | 8.123 | 5.624 | 6.949 | 5.872 | 9.485 | 12.623 | 13.653 | 15.119 | 13.978 |
| Depreciation & amort. | 2.623 | -2.728 | -2.092 | -759 | -848 | -1.027 | -878 | -1.626 | -2.154 | -1.773 | -2.429 | -1.888 | -1.564 | -1.228 |
| EBIT | 3.026 | 887 | 4.417 | 652 | 940 | 7.096 | 4.747 | 5.322 | 3.718 | 7.712 | 10.194 | 11.765 | 13.555 | 12.750 |
| Net financials | -1.412 | -1.637 | 44 | -223 | -159 | -182 | 8 | 67 | -36 | 223 | 532 | 415 | 882 | 992 |
| Profit before tax | 1.614 | -750 | 4.461 | 429 | 781 | 6.914 | 4.755 | 5.390 | 3.682 | 7.935 | 10.725 | 12.180 | 14.437 | 13.742 |
| Tax | 760 | -121 | 1.230 | 146 | 174 | 1.517 | 1.048 | 1.186 | 812 | 1.735 | 2.477 | 2.842 | 3.437 | 3.236 |
| Net profit | 854 | -629 | 3.231 | 284 | 607 | 5.397 | 3.707 | 4.203 | 2.870 | 6.199 | 8.248 | 9.338 | 11.000 | 10.506 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 28.726 | 32.420 | 31.801 | 27.345 | 26.952 | 56.085 | 18.141 | 18.341 | 21.042 | 24.415 | 26.552 | 36.218 | 35.915 | 34.858 |
| Equity | 13.236 | 11.068 | 10.699 | 9.482 | 10.089 | 28.718 | 6.200 | 6.696 | 4.066 | 10.265 | 12.314 | 13.404 | 15.000 | 14.506 |
| Long-term debt | 5.242 | 10.870 | 10.723 | 10.013 | 9.641 | 9.260 | 0 | 0 | 0 | 0 | 3.578 | 3.730 | 3.728 | 3.784 |
| Short-term debt | 8.948 | 9.981 | 9.741 | 7.760 | 7.093 | 14.154 | 11.942 | 11.645 | 16.976 | 14.149 | 10.660 | 19.084 | 17.187 | 16.568 |
| Total debt | 14.190 | 20.851 | 20.463 | 17.773 | 16.734 | 23.415 | 11.942 | 11.645 | 16.976 | 14.149 | 14.238 | 22.814 | 20.915 | 20.352 |
EBITDA margin
40.3%
This company
15.8%
Market median
+155% vs market
20122025
Equity ratio
41.6%
This company
38.2%
Market median
+9% vs market
20122025
Return on equity
72.4%
This company
18.4%
Market median
+293% vs market
20122025
Net profit margin
30.3%
This company
8.1%
Market median
+274% vs market
20122025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20122025
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW Management | Management | 2020 | — | — |
MC Management | Management | 2007 | — | — |
JT Management | Management | 2022 | — | — |
PS Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2007 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Plus Support A/S | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Valby Familieholding Aps
Plus Sundhed A/S Board members of Plus Sundhed A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Margrethe Wivel | Management | 0 companies |
| Michall Camaron Mason Søndergaard | Management | 0 companies |
| Jan Toftholm | Management | 0 companies |
| Peter Steen Hansen | Management | 0 companies |
| Henrik Busch | Board of Directors | 0 companies |
| Bjarne Henneman | Board of Directors | 0 companies |
| Pernille Reitz Jensen | Board of Directors | 0 companies |
| Christopher Moyell Juul | Board of Directors | 0 companies |
| Per Ingolf Hensen | Board of Directors | 0 companies |
| Tinna Damgaard-Sørensen | Board of Directors | 0 companies |
| Ib Oustrup | Chairman | 0 companies |
| Henrik Sven Sørensen | Chairman | 0 companies |
| Ole Folmer Jørgensen | Board of Directors | 0 companies |
| Erik Øvlisen | Board of Directors | 0 companies |
| Erik Hovgaard | Chairman | 0 companies |
| Carsten Henning Dahl | Board of Directors | 0 companies |
| Anette Laigaard | Board of Directors | 0 companies |
| Signe Larsen Vazquez | Board of Directors | 0 companies |
| Ragn Toghøj Gaihede | Board of Directors | 0 companies |
| Thomas Okkels | Board of Directors | 0 companies |